Month: October 2011

60% Of the Spanish population with cold automedica with medications without a prescription, such as aspirin

|

60% of the municipality with cold automedica with medications without a prescription, such as aspirin

-The cold is one of the most widespread conditions around the world. 45% Of the population afflicted in Spain

-responsible self-medication could allow the saving of more than 530 million euros

Barcelona, 2011-October the cold is one of the most widespread conditions around the world. According to the latest study Nielsen, in the last year it suffered more than 45% of Spaniards.

60% Of people that colds in Spain automedican with free delivery, such as acetylsalicylic acid medications to relieve symptoms, as reflected in this study.

According to Dr. Jesús Honoré, physician and Professor of clinical pharmacology from the University of Navarra, for this type of mild or moderate illness “ is not necessary to resort to strong painkillers or taking a higher dose to the recommended, because in most cases to take a simple Painkiller, such as an aspirin, is enough to relieve ailments such ”.

According to Dr. Honoré “ self-medication is good insofar as it is responsible, namely, that if suffering from a cold, doctors are the first to recommend that not is go to the consultation, that take a medication for free delivery, such as aspirin, it is enough ”. On the other hand, emphasizes that “ in the case of ailments common, mild or moderate, should never self-medicate with antibiotics, since they do not have any effect, except when combined with other infection ”.

Self-responsibility by citizens of their own State of health, in the case of moderate symptoms, allowing a reliable self-assessment in certain minor diseases, would entail a reduction of up 23.540 consultations of primary care. In addition, this decline in health care pressure from citizens would result a drop in the costs associated with medical consultations (531.065.877 euros, taking into account that the average cost of a medical visit is 22,72 EUR) according to Anefp (Association for the self-management) data from a study by the University Pompeu Fabra of Barcelona.

“ From October to March, with special incidence in December and January, has the largest number of cases of flu and colds, coinciding with the colder months. Although different pathologies, share many symptoms; headache, fever, malaise, etc. In both cases, the consumption of aspirin can help alleviate the discomfort ”, points out Dr. Honoré.
Causes
“ the convenience and immediacy are the most important causes for which the population is automedica, that have convenient and flexible way of medication is essential. In addition, it is key that this effect a rapid in relieving the symptoms ”. “ Also influences the great ignorance or inappropriate advice by acquaintances, friends or relatives who do not realize the importance of correctly administering a drug are the causes for the occasionally there may be problems with self-medication among the population ”, according to Dr. Honoré.

“ Patients normally resort to the same drug to alleviate ailments more frequent as in the case of acetylsalicylic acid ”, according to points Dr. Honorato. “ as that is an active principle which has more than 100 years proving its efficacy against mild to moderate pain ”.

Bayer HealthCare

Bayer HealthCare is a subsidiary of Bayer AG with headquarters in Leverkusen, their drugs and products for the medical sector, is among the leading innovative companies in the health sector. The company brings together the divisions Animal Health, Consumer Care, Diabetes Care, Intendis and Bayer HealthCare Pharmaceuticals. The aim of Bayer HealthCare is the research, development, production and marketing of innovative products to improve the health of humans and animals from around the world.

Bayer HealthCare adheres to the Spanish code of good practice of Farmaindustria.

Read More

Repsol promotes the use of the AutoGas sector of ambulances

|

Repsol promotes the use of AutoGas in the ambulance sector

-Repsol presents his bid for the AutoGas, the busiest in the world alternative fuel in the III national emergency and transportation health

-the use of the AutoGas assumes an average savings of 20% compared to traditional fuels and also contributes to the improvement of air quality urban.

– already circulate in Spain more than 250 ambulances with AutoGas.

-Repsol will have 85 stations on your network with AutoGas dispensers at end of year, and will intensify the opening of these points from 2012 with 100 service stations to the year

Castellón, 2011-October Repsol participates from 26 to 29 October in the III national meeting of urgencies and sanitary transport which takes place in the Palace of congresses de Castellón, presenting his bid for the AutoGas sector of ambulances.

At this meeting, organized by the National Federation of ambulance companies (ANEA), with the collaboration of the ministries of health, building and the Generalitat Valenciana, among other agencies and entities, Repsol shows the advantages and opportunities offered by the AutoGas.

The AutoGas, Repsol completes its range of high-tech, efficient and sustainable fuels, contributing to the improvement of the quality of urban air by their minimum values of emissions.

The AutoGas is more economical than traditional fuels. Cost per kilometre assume an average of 20% savings, without taking into account the lower costs of vehicle maintenance.

Other technical advantages of the AutoGas are its softer driving; a greater autonomy, to treat vehicles ‘ bifuel ’ which alternatively used petrol and AutoGas−; a longer duration of the engine due to cleaner combustion, and lower maintenance costs with more closely spaced oil changes.

The AutoGas or LPG from automotive contained in plans of aid and incentives for public administrations by purchase or adaptation of vehicles, both for companies and individuals.

100 stations annual AutoGas and 250 ambulances

Within the bet of Repsol for the AutoGas contained its plan of expansion of the network of points of this alternative fuel supplies. At year end the group will have 85 its network service stations equipped with AutoGas dispensers; and provided for installing AutoGas points at a rate of other 100 additional service stations in the coming years.

This investment effort, Repsol added a strategy that also facilitates individual delivery points or ‘ skids ’, for large companies of fleets of vehicles. Spain they already operate this system more than 200 ‘ skids ’ located in facilities of companies with vehicles using AutoGas.
In Europe are circulating about 8 million AutoGas vehicles. And Spain, with a more recent introduction, are already more than 5,000. Of these, about 250 are ambulances belonging to the fleets of sanitary transport of important sector entities such as Spanish Red Cross, and specialized companies such as ASV group, Ambuibérica, Ambunort, MP ambulance or ambulance Barbate.

The bet of Repsol is reinforced with a wide AutoGas vehicles by manufacturers offer. Brands such as Seat, Mercedes Benz, Renault, Opel, Skoda, Iveco and up to 15 manufacturers offer models with this modality ‘ bifuel ’ fuel.

Incentives for ambulances

Public aid for the acquisition and conversion of AutoGas vehicles, Repsol offer, companies associated with ANEA, aid to cover the additional cost of the vehicle.

To encourage the refuelling of this fuel in the same group of companies in service stations and independent suppliers or ‘ skids ’, the agreement provides for two lines of discounts on the price of fuel, through the card SOLRED Repsol −si fills in a station of servicio−, or direct discounts for bulk supplies for ‘ skids ’.

Read More

Treatment of ulcerative colitis active: demonstrated similar referral results between the standard dose of mesalazine (Pentasa ®) 2 g twice a day and the 4 g dose once a day.

|

active treatment of ulcerative colitis: demonstrated similar referral results between the standard dose of mesalazine (Pentasa ®) – 2 g twice a day – and the 4 g dose once a day.

According to a study presented in the United European Gastroenterology Week (UEGW), held in Stockholm

– it is estimated that some 70,000 people in Spain and 900,000 in Europe suffering from colitis ulcerative.

-diarrhea, abdominal pain and weight loss, with significant deterioration in the quality of life of the patient, as well as emotional distress and social isolation, these are some of the symptoms.

-patients fail often standard treatment, two daily doses of 2 g, with the risk of significant increase in symptoms, so a single daily dose can positively affect compliance.

Madrid, October 2011.- The results of a new estudio1 tabled yesterday in the United European Gastroenterology Week (UEGW), held in Stockholm show that a single daily dose of 4 g mesalazine (extended release granular ® Pentasa) is not less than the standard dose of 2 g administered twice per day, in the induction of remission in patients with active Ulcerative colitis.

The objective of the study was to show non-inferiority of a daily dose of mesalazine (extended release granular ® Pentasa) compared to the standard dosage – two times a day – for the remission of active Ulcerative colitis. Patients with active Ulcerative colitis mild to moderate were randomized to receive 4 g mesalazine once a day or 2 g mesalazine twice a day. During 4 weeks all received also rectal suspension mesalazine (1 g / day). Main criterion of assessment: clinical and endoscopic remission at week 8 (UC-DAI ≤ 1 score). Secondary evaluation criteria: clinical remission in weeks 4, 8, 12 (frequency of normal bowel movements, without blood in stool, not disease activity active according to comprehensive assessment of the health care provider), healing of the mucosa in week 8 (UC-DAI of the endoscopic appearance of the mucosa ≤ 1 score). The primary objective was reached. The study showed similar clinical and endoscopic remission rates for 4 g dose once a day and 2 g 2 times a day (52.1% and 41.8% respectively, p = 0,1402). Secondary objectives, the rates of clinical remission at weeks 4, 8 and 12 were similar between the dose of 4 g once a day and 2 g twice a day being 39.8% vs 27.6 &Amp; (p = 0.07 >), 45.1% vs 40.8% (p = 0.53), 92.4 per cent vs. 79.4% (p = 0.13); healing of the mucosa to 8 week by scoring UC-DAI < 1: 87.5 per cent versus 71.1 per cent (p = 0, 007).

Ulcerative colitis is a type of disease inflammatory bowel (IBD), which causes inflammation and ulcers throughout the interior of the colon. This swelling can interfere with the normal functioning of the colon, affecting the quality of life of patients, often causing cramps, swelling, diarrhea, bleeding, fatigue or weight loss. It is estimated that some 70,000 people in Spain and 900,000 in Europe suffer from ulcerative colitis.

The mesalazine is the usual treatment of ulcerative colitis mild to moderate. Patients with active Ulcerative colitis often receive multiple daily doses. However, the lack of adherence to treatment, significantly increases the risk of recurrence and persistence of the symptoms.

“ Know a long time that a single daily dose is effective to maintain remission in patients suffering from ulcerative colitis, mild to moderate. “This new study suggests that the benefits of the Administration once a day can also be extended to patients with active Ulcerative colitis,” said Dr. Bernard Flourie, Hospital de Lyon Sud, France.

About Pentasa ® (mesalazine)

Pentasa ® belongs to a class of anti-inflammatory drugs called aminosalicilatos, used to treat and control the symptoms of ulcerative colitis (CU).

Inflammatory bowel disease (IBD)

By inflammatory bowel disease (IBD) we understand a number of chronic diseases of the digestive system, including ulcerative colitis and Crohn’s disease. It is characterized by intermittent outbreaks with debilitating symptoms such as diarrhea, abdominal pain and weight loss, which can lead to a significant worsening of the quality of life of the patient, causing emotional distress and social isolation. In addition, patients may also experience a series of serious complications in their disease that may require treatment of by life and often surgery.

EC and UC are chronic diseases, and although the symptoms may disappear with treatment, tend to recur over time. Thus, patients at risk of future outbreaks unless they continue treatment to maintain remission.

During the acute phase stronger treatments may be prescribed to control inflammation, despite its potential harmful effects, looking for the improvement of the patient. The side effects of treatment of maintenance are considerably lower. Since it is very likely that patients must undergo treatment for life, they must be effective and safe. Mesalazine complies with these requirements, in addition to being comfortable Administration to the patient.

References

[1] Flourie, Bernard Once-Daily versus Twice-daily Mesalazine (PENTASA ®) for Active Ulcerative Colitis: Efficacy Results from MOTUS, Multicentre, Randomised, Investigator-Blinded Study, Controlled, UEGW Abstract number 0P95

[1] Kane, Am J Med. 2003; 114: 39-43

[1] Kane, S Am J Gastroenterology 2001, 96; 2929-33

Read More

It helps to raise awareness of prostate cancer leaving you grow the moustache

|

helps raise awareness of prostate cancer leaving you grow the moustache

an early detection improves a 90% cure

-the CBP supports the campaign ‘ Movember ’ to be held next November in different countries around the world, among which is Spain.

– each year are diagnosed in our country 18,800 new cases of this type of tumor.

Madrid, October 2011.- The circle of Prostática brachytherapy (CBP) encouraged men to participate in ‘ Movember ’, an initiative which each year is carried out in different countries around the world, which include Spain, and which aims to raise awareness of prostate cancer. This requires that men should be left believing the mustache next month of November as a way of raising awareness about male health.

The next edition of this initiative, which emerged in Australia in 2003 and is in line with the awareness campaign carried out by the CBP will begin next November 1, day in which all the men who dare to participate must be completely afeitados. Since then and throughout the month, the Mo Bros, which is how they are called the participants will have to let grow his mustache becoming human billboards that will generate conversations in your environment on prostate cancer. Iran also telling their experience and uploading photos on the page of Movember (http://es.movember.com), which must be registered.

In this way, and with the help of the Mo Sistas (women who support the Mo Bros), will help to raise funds, raise awareness and raise awareness of this type of tumor in which every year are diagnosed more than 18,800 new cases in Spain, causing the death of 5,800 men.

This awareness is key, because the asymptomatic nature of prostate cancer, men of more than 50 years (45 if there is a family history) should undergo Urologic annual reviews to verify the State of health of your prostate gland. A practice which is not yet entrenched in sanitary routines of Spanish men, due to the fear that means visiting the urologist. These periodic checks allow holding an early diagnosis and therefore, the application of proper treatment with an increase in the possibilities of healing of 90%.

Also with the detection of the tumor in its early stages, it is possible to apply a little aggressive treatments for the patient, which they maintain their quality of life and minimize side effects, as is the case of prostate brachytherapy.

This technique involves the introduction of seeds radioactive iodine-125 directly within the prostate, so that its action is concentrated in the gland and significantly reduces the possibility of radiation to reach the adjacent healthy organs (rectum and bladder). As a result, the usual such as impotence and urinary incontinence side effects, decrease greatly.

In this sense, as it has been shown in studies, prostate brachytherapy can offer a better quality of life for the patient, with other treatments such as radiotherapy and the Prostatectomy. are recently comparative study made by the Catalan Institute of Oncology (ICO), the Hospital de Bellvitge and the Municipal Institute of medical research (IMIM-Hospital del Mar)along with other Spanish medical institutions of prestige has so verified.

These working groups are the Onkologikoa Foundation of Gipuzkoa, the Capio Hospital General de Catalunya, the Oncology Centre of Galicia, elComplexo Hospital University of A Coruña, the Hospital Ramón y Cajal of Madrid, Regional Hospital Carlos Haya in Málaga, the Virgen del Rocío Hospital of Sevilla, Hospital de la Santa Creu i Sant Pau, Puigvert Foundation, and the IMOR Foundation of Barcelona.

Read More

The first magnetic resonance of limbs open of high field of 1.5 Teslas in the Basque country Bilbao placed at the forefront of technology

|

the first magnetic resonance of limbs open high field of 1.5 Teslas in the Basque country puts Bilbao at the technological forefront

-Use enabled limb – of the elbow to the fingers of the hand and knee to the toes of the foot – and allows the patient fits, relaxed, in his armchair and do not have to enter into the machine.

-La Optima MR430s 1.5 Teslas of GE Healthcare has implemented a software of special sequences that refined document image quality and reduce the risk of error in interpretacidoes them when there are artifacts ferromagnetic (nails, Staples, etc.).

-the new magnetic resonance eliminates the feeling of claustrophobia of the patient.

-RM Bilbao has carried out more than 200,000 magnetic resonance throughout their nearly 25 years of life

Bilbao, October 2011. The inauguration of the new premises of RM Bilbao to give Bilbao of a cutting edge diagnostic of resonance facility and it brings up Bilbao the first magnetic resonance of limbs open high field of 1.5 teslas is installed in the Basque country. The Optima MR430s 1.5 Teslas of GE Healthcare stands out by its unique design and have implemented a software of special sequences that refined document image quality and reduce the risk of misunderstanding of them when there are artifacts ferromagnetic (nails, Staples, etc.) in the interior of the human body.

The new MRI allows the patient fits, relaxed, in his armchair and does not have to enter the machine’s entire body. Despite outlined comfort, the new open MRI is capable of accessing very small fields of view with very high resolution, giving reliability to the diagnostic imaging. Among other applications, this avant-garde system also reduces the feeling of claustrophobia of the patient.

A complete technological renovation marks the transfer of RM Bilbao installations, located up on 22 September in Hospital San Francisco Javier, to its current address in calle Licenciado Poza No. 10. Since its foundation in 1987, RMB has made more than 200,000 MRIs in Bizkaia, figure that the company becomes a focal point in all of the historical territory.

Beyond of the incorporation of this cutting-edge technology, the magnetic resonance applications in recent times have been expanded significantly its field of activity. For example, the possibility of obtaining 3D sequences to assess complete anatomies (without the possibility of obviating any structure).

Thanks to these new techniques of diseases such as the Alzheimer study or studies of tractography (which allows to evaluate the impact of injuries to the brain and Medulla on the paths of interconnection of the different neural areas among themselves) is possible. The possibility of a whole-body resonance, suitable for the diagnosis of myeloma, metastasis or lymphomas, among others, as well as conducting abdominal vascular tests without contrast, are some of the leading-edge applications offered in new facilities.

The new center of RM Bilbao located on calle Licenciado Poza has thus two new teams of high field, one of traditional configuration with the most advanced techniques, and the new Optima 430s of GE Healthcare for the study of limbs.

Read More

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips